Alpiniae oxyphyllae Fructus in Alzheimer’s Disease: Multi-Target Mechanisms, Current Evidence, and Future AI-Driven Perspectives
- 1Health Science Center, Ningbo University, Ningbo 315211, China
Abstract
Alpiniae oxyphyllae Fructus (Zingiberaceae; Alpinia oxyphylla Miq) (AOF) is a traditional Chinese medicinal and edible homologous material rich in bioactive metabolites, including flavonoids, terpenes, and sesquiterpenes. Its multiple metabolites and multi-target nature confer unique advantages for cognitive function and neuroprotection. However, recent advances in extraction techniques, the discovery of AOF effects, and novel ameliorative mechanisms against Alzheimer’s disease (AD) require an updated review. This review systematically expands on the botanical features, traditional dietary applications, and quality control of AOF raw materials, as well as its AD-ameliorating effect, in vivo absorption, toxicological safety, and extraction technology optimization strategies. Moreover, we explored the emerging mechanisms underlying the effectiveness of AOF and its bioactive metabolites in improving AD, including effects on glial cell function, the gut–brain axis, brain metal ions, and advanced glycation end products. This review comprehensively summarizes preclinical studies, clinical research, and commercially available products related to AOF and its metabolites. It also expounds upon the potential impetus that artificial intelligence could offer AOF research in the future. In summary, this review provides innovative technologies, in-depth mechanistic analyses, and novel research directions for exploring AOF extracts and their bioactive metabolites to offer strategic guidance for identifying new functional factors and drug candidates to combat AD.
Related
- Peptides and Peptide Analogues Targeting Acetylcholinesterase-Associated Mechanisms in Alzheimer’s Disease and Dementias: Evidence Gaps, Design Strategies, and Translational Perspectives
- Dexmedetomidine as a potential neuroprotective agent against Alzheimer’s disease: molecular mechanisms and therapeutic perspectives
- Protein glycosylation and glycation in Alzheimer's disease: mechanisms, crosstalk, and therapeutic perspectives
- Low-energy extracorporeal shock wave therapy for interstitial cystitis/bladder pain syndrome: mechanisms, evidence, and translational perspectives—a narrative review
- Diet, Obesity and Cardiovascular Health: Molecular Mechanisms, Clinical Evidence and Future Perspectives
BibTeX
@article{qin2026alpiniae,
title = {{Alpiniae oxyphyllae Fructus in Alzheimer’s Disease: Multi-Target Mechanisms, Current Evidence, and Future AI-Driven Perspectives}},
author = {Qihan Qin and Qingmin Yan and Keyi Zhu and Jingyuan Miao and Miaoxin Yang and Zhenghao Wu and Chenhan Fan and Ping Jiang and Guoqing Wu and Qinwen Wang},
journal = {Molecules},
year = {2026},
month = oct,
doi = {10.3390/molecules31203681},
url = {https://www.mdpi.com/1420-3049/31/20/3681},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Alpiniae oxyphyllae Fructus in Alzheimer’s Disease: Multi-Target Mechanisms, Current Evidence, and Future AI-Driven Perspectives
AU - Qihan Qin
AU - Qingmin Yan
AU - Keyi Zhu
AU - Jingyuan Miao
AU - Miaoxin Yang
AU - Zhenghao Wu
AU - Chenhan Fan
AU - Ping Jiang
AU - Guoqing Wu
AU - Qinwen Wang
PY - 2026
DA - 2026/10/14
JO - Molecules
DO - 10.3390/molecules31203681
UR - https://www.mdpi.com/1420-3049/31/20/3681
AB - Alpiniae oxyphyllae Fructus (Zingiberaceae; Alpinia oxyphylla Miq) (AOF) is a traditional Chinese medicinal and edible homologous material rich in bioactive metabolites, including flavonoids, terpenes, and sesquiterpenes. Its multiple metabolites and multi-target nature confer unique advantages for cognitive function and neuroprotection. However, recent advances in extraction techniques, the discovery of AOF effects, and novel ameliorative mechanisms against Alzheimer’s disease (AD) require an updated review. This review systematically expands on the botanical features, traditional dietary applications, and quality control of AOF raw materials, as well as its AD-ameliorating effect, in vivo absorption, toxicological safety, and extraction technology optimization strategies. Moreover, we explored the emerging mechanisms underlying the effectiveness of AOF and its bioactive metabolites in improving AD, including effects on glial cell function, the gut–brain axis, brain metal ions, and advanced glycation end products. This review comprehensively summarizes preclinical studies, clinical research, and commercially available products related to AOF and its metabolites. It also expounds upon the potential impetus that artificial intelligence could offer AOF research in the future. In summary, this review provides innovative technologies, in-depth mechanistic analyses, and novel research directions for exploring AOF extracts and their bioactive metabolites to offer strategic guidance for identifying new functional factors and drug candidates to combat AD.
SN - 1420-3049
ER -